POLISCOPE
Back to feed
HR4348FEDERALpassed_chamber
Passed

Congress moves to reauthorize the Kay Hagan Tick Act for tick-borne disease research and prevention

Original title: To reauthorize the Kay Hagan Tick Act, and for other purposes.

July 21, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently passed_chamber. The next step in the legislative lifecycle is Signed.

Last action
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.Jul 21, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

Reauthorization ensures the continuation of federal funding and coordination for programs that track and combat tick-borne illnesses, which directly impacts public health surveillance and medical research priorities for residents in regions with high tick activity.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Public health agencies

These agencies rely on the authorization provided by this Act to conduct surveillance and implement disease prevention programs.

Medical research institutions

These institutions receive federal support for research into tick-borne illnesses facilitated by the Act.

What changed

Current stage: passed_chamber.

What's next

Signed.

Summary

The Kay Hagan Tick Act is moving toward reauthorization, which would continue federal support for research, prevention, and public health efforts related to tick-borne diseases. The bill has been received in the Senate and placed on the legislative calendar for consideration.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

Reauthorization ensures the continuation of federal funding and coordination for programs that track and combat tick-borne illnesses, which directly impacts public health surveillance and medical research priorities for residents in regions with high tick activity.

Frequently Asked Questions

What does the Kay Hagan Tick Act do?
The Act provides a framework for federal research, surveillance, and prevention programs aimed at reducing the impact of tick-borne diseases.
What is the current status of this bill?
As of July 10, 2025, the bill has been received in the Senate and placed on the legislative calendar for future action.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Legislative Continuity

The bill serves as a continuation of existing public health policy rather than a new initiative, indicating a focus on maintaining current disease control infrastructure.

Connected Entities

organizationSenate Legislative CalendarThe current procedural status of the bill.Map →

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record